Don't take this medicine. The post Common Cholesterol Medication Recalled Over ‘Failed’ Testing appeared first on Mandatory.

Over 140,000 bottles of atorvastatin calcium tablets—the generic version of Lipitor—were pulled from shelves across all 50 U.S. states beginning September 19, 2025, after routine quality checks revealed a critical problem: the tablets failed dissolution tests,

The recall comes after the maker determined the drug may not dissolve or release its active ingredient in a way that meets regulations and standards.

Your prescription may be involved. The FDA explains why suddenly stopping your medication is more harmful than taking it.

The recall of a widely used statin taken by those with high cholesterol is raising more attention than recalls sometimes do.

The FDA's recall currently lists bottles of 10-mg, 20-mg, 40-mg and 80-mg atorvastatin calcium tablets manufactured by India-based Alkem Laboratories and distributed by Ascend Laboratories as impacted medications. The recalled bottles contain different quantities of the tablets, ranging from 90-count to 1000-count bottles.

The FDA announced a nationwide recall of over 140,000 bottles of a prescription cholesterol medication due to “failed dissolution specifications,” announced earlier this month. Ascend Laboratories of New Jersey recalled certain bottles of atorvastatin calcium tablets,

Ascend Laboratories, LLC, a New Jersey-based pharmaceutical company, has recalled over 141,000 bottles of cholesterol medication. An advisory from the company suggests that the drugs may have failed to dissolve at a standard rate.